Recent study found that sex differences in microglial activation exist in themodulation of energy homeostasis and identified CX3CR1 signaling as a potential therapeutictarget for the treatment of metabolic diseases in mice such as obesity19. The gene discussed is CX3CR1; the disease is Other metabolic disease.